DRUG

Vernalis hit by fresh U.S. setback for cough and cold drug

Vernalis hit by fresh U.S. setback for cough and cold drug

Published 07/08/2017

Shares in Vernalis fell more than 15 percent on Monday as the British biotech company backed by fund manager Neil Woodford and his previous employer Invesco announced a fresh setback for a key new drug in the United States. [more…]

Cancer patients should check drug list with pharmacist

Cancer patients should check drug list with pharmacist

Published 30/06/2017

By Carolyn Crist(Reuters Health) - Cancer patients receiving chemotherapy should have all their medications and herbal supplements reviewed by a phar

[more…]

Israel`s Gamida Cell raises $40 million for bone marrow trial

Israel`s Gamida Cell raises $40 million for bone marrow trial

Published 19/06/2017

Israel's Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants.

[more…]

Many U.S. cancer patients struggle to afford life-saving medications

Many U.S. cancer patients struggle to afford life-saving medications

Published 22/02/2017

By Madeline Kennedy(Reuters Health) - As cancer drug costs rise, U.S. cancer patients are more likely than other medical patients to struggle with pa

[more…]

Express Scripts says prescription drug spending slowed in 2016

Express Scripts says prescription drug spending slowed in 2016

Published 06/02/2017

Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, said prescription drug spending for its members slowed to less than 4 percent in 2016, at a time when scrutiny of drug price hikes has intensified.

[more…]

Serial testers and cursory checks: India`s flawed generic drug trials business

Serial testers and cursory checks: India`s flawed generic drug trials business

Published 27/12/2016

A woman talks on a mobile phone as she walks past the closed research facility of Semler Research Centre in Bengaluru, India, October 13, 2016. REUTERS/Abhishek N. Chinnappa

Vasudeva Prakash left his job as a mechanic in Hyderabad three years ago for what he calls a more lucrative career: taking part in clinical trials on generic drugs.

[more…]

Richter withdraws marketing application for biosimilar drug

Richter withdraws marketing application for biosimilar drug

Published 19/12/2016

Hungarian pharmaceuticals firm Richter has withdrawn its marketing application for one of its biosimilar drugs from the European Medicines Agency in anticipation of a possible negative assessment, the company said on Monday.

[more…]

Big price hikes seen in drug that prevents overdose deaths

Big price hikes seen in drug that prevents overdose deaths

Published 12/12/2016

By Gene Emery(Reuters Health) - Two of the largest suppliers of the life-saving drug naloxone have dramatically increased their prices in recent year

[more…]

Richter`s generic osteoporosis drug gets EU recommendation

Richter`s generic osteoporosis drug gets EU recommendation

Published 15/11/2016

Richter received a positive opinion from European regulators recommending that its generic osteoporosis drug Terrosa be granted marketing authorization, the Hungarian drug maker said in a statement on Monday.

[more…]

Breast cancer chemo costs vary despite similar effectiveness

Breast cancer chemo costs vary despite similar effectiveness

Published 11/10/2016

By Lisa Rapaport(Reuters Health) - Chemotherapy regimens for breast cancer can vary wildly in price even when they are comparable in their ability to

[more…]